Resultados da pesquisa - Portal para modelos de dados médicos (portal MDM)

CALGB: 80802 Imaging Form NCT01015833

- 21/06/2015 - 1 Formulário, 4 Grupos de itens, 22 Elementos de dados, 1 Idioma

Grupos de itens: Header, Patient demographics, Evaluation of lesions, Footer

CALGB: 80802 Imaging Form NCT01015833 Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=741B4E5D-7BA2-2FBB-E040-BB89AD432970

E1208 Treatment Form NCT01004978

- 16/06/2015 - 1 Formulário, 8 Grupos de itens, 40 Elementos de dados, 1 Idioma

Grupos de itens: Header, Patient demographics, Vital Status, Patient Characteristics, Therapy Administered, TACE Administration, Non-Protocol Therapy, Comments

E1208 Treatment Form NCT01004978 Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6FCB9730-7048-93EE-E040-BB89AD434904

E1208 Second Primary Form NCT01004978

- 16/06/2015 - 1 Formulário, 5 Grupos de itens, 22 Elementos de dados, 1 Idioma

Grupos de itens: Header Module, Patient demographics, Data amendment, Second primary cancer assessment, Comments

E1208 Second Primary Form NCT01004978 Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6FC65FB7-39D1-797B-E040-BB89AD4315BB

E1208 Baseline Disease Evaluation Form (RECIST) NCT01004978

- 16/06/2015 - 1 Formulário, 6 Grupos de itens, 30 Elementos de dados, 1 Idioma

Grupos de itens: Header Module, Patient demographics, Data amendment, TARGET LESIONS, NONTARGET LESIONS, Comments

E1208 Baseline Disease Evaluation Form (RECIST) NCT01004978 Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6FC99A84-9671-F189-E040-BB89AD4377B4

E1208 Off-Treatment Form NCT01004978

- 16/06/2015 - 1 Formulário, 8 Grupos de itens, 26 Elementos de dados, 1 Idioma

Grupos de itens: Header Module, Patient demographics, Data amendment, Vital Status, Protocol therapy, Off-protocol treatment, Section II, Comments

E1208 Off-Treatment Form NCT01004978 Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7041BC2E-D506-911B-E040-BB89AD432643

E1208 Source Document Tracking Coversheet NCT01004978

- 08/06/2015 - 1 Formulário, 1 Grupo de itens, 12 Elementos de dados, 1 Idioma

Grupo de itens: ECOG clinical trial administrative data

E1208 Source Document Tracking Coversheet NCT01004978 Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6FDC3F1E-42D2-1043-E040-BB89AD430FD1

E1208 Follow-Up Disease Evaluation Form (RECIST) NCT01004978

- 08/06/2015 - 1 Formulário, 11 Grupos de itens, 33 Elementos de dados, 1 Idioma

Grupos de itens: ECOG clinical trial administrative data, Data amendment, ON TREATMENT, OFF TREATMENT, Disease Assessment, TARGET LESIONS, NONTARGET LESIONS, New Lesions, Overall Response per RECIST Criteria - Target, Nontarget and New Lesions, Symptomatic Deterioration, Footer Module

E1208 Follow-Up Disease Evaluation Form (RECIST) NCT01004978 Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6FDF6DBB-2BD5-6632-E040-BB89AD434639

E1208 Nontarget Lesions Supplemental Form (RECIST) NCT01004978

- 08/06/2015 - 1 Formulário, 6 Grupos de itens, 24 Elementos de dados, 1 Idioma

Grupos de itens: Header Module, Data amendment, ON TREATMENT, OFF TREATMENT, NONTARGET LESIONS, Footer Module

E1208 Nontarget Lesions Supplemental Form (RECIST) NCT01004978 Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6FCA48E1-2773-7263-E040-BB89AD434A3E

E1208 Maintenance Sorafenib/Placebo Treatment Form NCT01004978 - E1208 Maintenance Sorafenib/Placebo Treatment Form NCT01004978

- 08/06/2015 - 1 Formulário, 10 Grupos de itens, 34 Elementos de dados, 1 Idioma

Grupos de itens: Header, Patient demographics, ON TREATMENT, Data amendment, Vital Status, Reporting Period, Patient Characteristics, Therapy Administered, Non-Protocol Therapy, Footer Module

E1208 Maintenance Sorafenib/Placebo Treatment Form NCT01004978 Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6FF38FDB-A4BA-3C8D-E040-BB89AD432B43

Liver Cancer NCT01015833 On-Study - CALGB Solid Tumor Evaluation Form (RECIST 1.1) - 2946223v1.0 - CALGB Solid Tumor Evaluation Form (RECIST 1.1)

- 09/01/2015 - 1 Formulário, 7 Grupos de itens, 35 Elementos de dados, 1 Idioma

Grupos de itens: Header Module, Header, Report Period, TARGET LESIONS, Comments, NON-TARGET LESIONS, Footer Module

CALGB Solid Tumor Evaluation Form (RECIST 1.1) Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=746D8651-FF47-E158-E040-BB89AD4366AF

Liver Cancer NCT01015833 Lab - CALGB: 80802 Sample Submission Form - 2943746v1.0 - CALGB: 80802 Sample Submission Form

- 09/01/2015 - 1 Formulário, 4 Grupos de itens, 25 Elementos de dados, 1 Idioma

Grupos de itens: Header Module, Module 2, Shipping Information, Footer Module

CALGB: 80802 Sample Submission Form Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=741BA0BF-5B36-06EF-E040-BB89AD434B15

Liver Cancer NCT01004978 Follow-Up - E1208 Long-Term Follow-up Form - 2926924v1.0 - E1208 Long-Term Follow-up Form

- 08/01/2015 - 1 Formulário, 9 Grupos de itens, 34 Elementos de dados, 1 Idioma

Grupos de itens: Header Module, Header, Section I - Vital Status, Section II - Reporting Period, Section III - Notice of New Primary, Section IV - Disease Follow-up Status, Section V - Adverse Events, Section VI - Non-Protocol Therapy Prior To Progression, Footer Module

E1208 Long-Term Follow-up Form Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=705708B9-0164-E0FE-E040-BB89AD435F94

Palavras-chave

Índice

Modelos de dados selecionados